JP3545057B2 - Cosmetics - Google Patents

Cosmetics Download PDF

Info

Publication number
JP3545057B2
JP3545057B2 JP20728794A JP20728794A JP3545057B2 JP 3545057 B2 JP3545057 B2 JP 3545057B2 JP 20728794 A JP20728794 A JP 20728794A JP 20728794 A JP20728794 A JP 20728794A JP 3545057 B2 JP3545057 B2 JP 3545057B2
Authority
JP
Japan
Prior art keywords
solution
added
active oxygen
water
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP20728794A
Other languages
Japanese (ja)
Other versions
JPH0867616A (en
Inventor
恒雄 難波
重利 門田
健次 下村
浩一 飯田
幸久 山辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP20728794A priority Critical patent/JP3545057B2/en
Publication of JPH0867616A publication Critical patent/JPH0867616A/en
Application granted granted Critical
Publication of JP3545057B2 publication Critical patent/JP3545057B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Description

【0001】
【産業上の利用分野】
本発明は美白作用が高く、且つ肌荒れなどに有効な化粧料に関する。
【0002】
【従来の技術】
シロバナチョウセンアサガオは、学名をダツラ ストラモニウム エル(Datura stramonium L.)と称し、ナス科の植物で、ヨウシュチョウセンアサガオ又は曼陀羅とも呼ばれ、中国各地の村落周辺や道端に生える1年生草本である。
従来は、気管支喘息、慢性喘息性気管支炎、胃痛、リウマチ痛等に用いられて来た。
【0003】
一方、化粧料の原料として使用できる美白作用のある物質としては、種々の物質が知られているが、合成品は、長期間人間の肌に適用した場合の安全性の保証がなく、使用が制限されつつある。
一方、天然物では美白作用が弱いものが多い。
しかし、人の肌に対する安全性の面から、天然物で、多年人が医薬として飲用したり、人が食したりして安全性の面で保証されており、しかも美白作用が強く、更に皮膚に対する効果を併せもつような物質が望まれていた。
【0004】
【発明が解決しようとする課題】
本発明の目的は、皮膚に適用して安全性が保証されており、しかも美白作用が大きく、更に肌荒れなどに有効な成分を含んだ化粧料を提供することである。
【0005】
【課題を解決するための手段】
本発明者らは、前記の課題を解決するため、すでに多年にわたって医薬として飲用されたり、食用に供されて、人体に対する安全性が確認されている植物をスクリーニングして調べ、化粧品として利用価値のあるものを検討した。
【0006】
その結果、シロバナチョウセンアサガオが化粧品原料として、或いは医薬部外品として非常に有効性を有することを見出した。
確認された効果として美白作用、活性酸素抑制作用、抗酸化作用が確認された。
すなわち、本発明は、シロバナチョウセンアサガオルの種子から、水或いは親水性有機溶媒、又はこれらの混合溶媒で抽出した抽出物を含む化粧料である。
【0007】
シロバナチョウセンアサガオの利用方法としては、水或いは親水性有機溶媒例えば、エタノール、メタノール、アセトン等で抽出する。しかしながら、化粧品原料の抽出であるから、水或いはエタノール或いはこれの混合溶媒での抽出が好ましいのは当然である。
また、場合によっては、グリセリン、1,3ブチレングリコール、プロピレングリコール等の多価アルコール又は多価アルコールと水の混液も抽出に利用できる。
またさらに凍結乾燥して粉体として利用することも利用方法によっては有効である。
【0008】
この物質を他の化粧品原料例えばスクワラン、ホホバ油等の液状油、ミツロウ、セチルアルコール等の固体油、各種の活性剤、グリセリン、1,3ブチレングリコール等の保湿剤や各種薬剤等を添加してさまざまな剤形の化粧料を調製することができる。例えばローション、クリーム、乳液、パック等で目的に応じて利用形態を考えればよい。
【0009】
本発明の抽出物としての効果は、前記した如く、第1に美白作用である。
第2に活性酸素抑制作用である。空気中には酸素があり、これがないと生物(嫌気性のものを除く)は存在しえない。しかし酸素は紫外線や酵素等の影響を受けて活性酸素になる。活性酸素は脂肪酸を酸化し過酸化物を生成させる。生体の生体膜のリン脂質も酸化させ、障害を与える。
その上、生成した過酸化物と活性酸素はDNAに損傷を与え、老化を促進するといわれている。この活性酸素は、チロシンからメラニンを作る機構にも影響を与え皮膚の黒化にも関与している。この活性酸素を抑制することは皮膚にとって重要な、言い換えれば化粧料に求められている重要な要素である。
本発明のシロバナチョウセンアサガオは又この活性酸素抑制作用、抗酸化性も有している。
【0010】
【実施例】
以下に実際の利用方法である実施例を記載するが、本発明はこの実施例によって何ら限定されるものではない。
本発明で使用したシロバナチョウセンアサガオの抽出物の製造例を次に示す。
【0011】
(製造例1)
シロバナチョウセンアサガオの種子(乾燥品)を10gにエタノール300mlを加えて時々撹拌しつつ5日間放置した。これをエバポレートしたのち、濾過後凍結乾燥した。
【0012】
(製造例2)
シロバナチョウセンアサガオの種子(乾燥品)を10gに50%エタノール水溶液300mlを加えて時々撹拌しつつ5日間放置した。これをエバポレートしたのち、濾過後凍結乾燥した。
【0013】
(製造例3)
シロバナチョウセンアサガオの種子(乾燥品)を10gに精製水300mlを加えて3時間加熱する。これを放冷した後濾過後凍結乾燥した。
【0014】

Figure 0003545057
【0015】
Figure 0003545057
AとBをそれぞれ計量し、70℃まで加温し、BにAを撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30℃まで冷却した。
【0016】
実施例3は実施例1の製造例1の抽出物を製造例3の抽出物に変え作成したもの。
【0017】
(チロシナーゼ活性阻害試験)
(試験方法)
マックルバルン(Mcllvaln)緩衝液0.9ml、1.66mMチロシン(Tyrosine)溶液1.0ml、前記製造例(凍結乾燥品)の0.1wt/v%水溶液(溶解しにくい場合はエタノールを加えて溶解したのち精製水を加えて、エバポレートし、エタノールを除去したのち、0.1wt/v%になるように調製した)1.0mlをスクリューバイアルにとり、37℃恒温水槽中で5分以上加温した。
チロシナーゼ溶液(Sigma社製、マッシュルーム由来、914ユニット/ml)0.1mlを加え、37℃恒温水槽中で保温し、10分後に475nmで吸光度を測定した。
対照として、上記試料液のかわりに純水を加え同様に測定した。
この試験では試料の終濃度は0.033%となる。
Figure 0003545057
その結果を表1に示す。
【0018】
【表1】
Figure 0003545057
【0019】
(活性酸素抑制試験)
活性酸素を抑制する効果を測定する方法は各種あるが、今回以下の方法を利用した。
Figure 0003545057
上の試薬の混合物を2.4ml、検体を0.3ml加えてキサンチンオキシナーゼ(予め検体を水とし、実験するとき、吸光度が1分当たり0.02前後上昇するように上記のリン酸カリウム緩衝液で調整しておく)液を0.1ml加えて直ちに吸光度(560nm)を測定する。(測定は2分位し、直線性を確認する)
計算式 阻害率=((A−B)/A)×100
A:検体を水としたときの1分当たりの吸光度の変化
B:検体の1分当たりの吸光度の変化
濃度段階を数段階行い、50%活性酸素生成阻害濃度を探した。検体の作成方法は前記製造例(凍結乾燥品)を適当な濃度の水溶液(溶解しにくい場合はエタノールを加えて溶解したのち精製水を加えて、エバポレートし、エタノールを除去したのち適当な濃度%となるように調製した)とした。
製造例2についての、50%活性酸素生成阻害濃度の結果を表2に示す。
【0020】
【表2】
Figure 0003545057
【0021】
(抗酸化試験)
以下の試験液をネジキャップ付50ml試験管に作成した。
検体 5mg
2%リノール酸エタノール溶液 10ml
0.1M,pH7.0リン酸緩衝液 10ml
精製水 5ml
これを50℃の恒温槽に遮光して放置する。
これを恒温槽に入れる前と数日間隔で下記の測定をした。
試験液0.125ml、75%エタノール12.125ml、30%チオシアン酸アンモニウム0.125mlを加えて撹拌し3分間放置後、0.02N塩化第一鉄3.5%HCl水溶液0.125mlを加えて撹拌し3分間放置後波長500nmで吸光度を測定した。セル長10mm、対照セルは試験液を水に置き換えたもの。
その結果を表3、表4に示す。
【0022】
【表3】
Figure 0003545057
【0023】
【表4】
Figure 0003545057
【0024】
(使用テスト)
女性6名づつの顔面を左右に分け、一方を実施例、もう一方を比較例として毎日、1回以上使用してもらって、3月後、アンケートした。なお、比較例は実施例より製造例の各種のシロバナチョウセンアサガオの抽出物を水にかえたものである。(比較例1,2)なお、12名を2班にわけ、下記の表5の試料を使って実験した。
【0025】
【表5】
Figure 0003545057
【0026】
判定基準は以下のようでこの評点の合計値をまとめたのが以下の表6である。
実施例の方が非常によい 3
実施例の方がかなりよい 2
実施例の方がややよい 1
差がない 0
比較例の方がややよい −1
比較例の方がかなりよい −2
比較例の方が非常によい −3
【0027】
【表6】
Figure 0003545057
【0028】
【発明の効果】
本発明の化粧料は、美白作用に優れ、更に活性酸素抑制作用、抗酸化作用にも優れているので、肌荒れを防止する効果が大きい。
古くより、内服薬として用いられて来たので、人体に対する安全性の面で保証されている。[0001]
[Industrial applications]
The present invention relates to a cosmetic having a high whitening effect and effective for rough skin.
[0002]
[Prior art]
Scientific name is Datsura stramonium L., the scientific name is Datura stramonium L. It is a plant of the Solanaceae family. .
Conventionally, it has been used for bronchial asthma, chronic asthmatic bronchitis, stomach pain, rheumatic pain and the like.
[0003]
On the other hand, various substances having a whitening effect that can be used as a raw material for cosmetics are known, but synthetic products have no guarantee of safety when applied to human skin for a long period of time, and are not used. It is being restricted.
On the other hand, many natural products have a weak whitening effect.
However, from the viewpoint of safety for human skin, it is a natural product, which is guaranteed for safety by many people drinking or eating it as a medicine, and has a strong whitening effect. A substance having both effects has been desired.
[0004]
[Problems to be solved by the invention]
An object of the present invention is to provide a cosmetic composition which is applied to the skin, guarantees safety, has a large whitening effect, and further contains an effective ingredient for rough skin.
[0005]
[Means for Solving the Problems]
The present inventors, in order to solve the above-mentioned problems, have been screened and examined for plants that have already been drunk as medicines or edible for many years, and that have been confirmed to be safe for the human body. I considered something.
[0006]
As a result, it has been found that white narcissus morning glory is very effective as a cosmetic raw material or as a quasi-drug.
As the confirmed effects, a whitening effect, an active oxygen suppressing effect, and an antioxidant effect were confirmed.
That is, the present invention is a cosmetic that contains an extract extracted from the seeds of Asparagus japonicum with water or a hydrophilic organic solvent, or a mixed solvent thereof.
[0007]
As a method of utilizing Aspergillus niger, extraction is performed with water or a hydrophilic organic solvent such as ethanol, methanol, or acetone. However, it is a matter of course that extraction with water, ethanol or a mixed solvent thereof is preferable because it is the extraction of cosmetic raw materials.
In some cases, a polyhydric alcohol such as glycerin, 1,3-butylene glycol, propylene glycol, or a mixture of polyhydric alcohol and water can also be used for extraction.
It is also effective to freeze-dry and use it as a powder depending on the method of use.
[0008]
This material is added with other cosmetic ingredients such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol, and various chemicals. Various dosage forms of cosmetics can be prepared. For example, a use form may be considered depending on the purpose, such as a lotion, a cream, a milky lotion, and a pack.
[0009]
As described above, the effect of the extract of the present invention is firstly a whitening effect.
The second is an active oxygen suppressing action. There is oxygen in the air, without which organisms (except anaerobic ones) cannot exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids to form peroxides. Phospholipids in biological membranes of living organisms also oxidize and cause damage.
In addition, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. This active oxygen affects the mechanism of producing melanin from tyrosine and is also involved in skin darkening. Suppressing this active oxygen is important for the skin, in other words, an important factor required for cosmetics.
The Aspergillus vulgaris according to the present invention also has this active oxygen suppressing action and antioxidant property.
[0010]
【Example】
An embodiment which is an actual use method will be described below, but the present invention is not limited to the embodiment.
The production example of the extract of Aspergillus niger used in the present invention is shown below.
[0011]
(Production Example 1)
300 g of ethanol (300 g) was added to 10 g of the seeds of Datura stramonium (dried product), and the mixture was allowed to stand for 5 days with occasional stirring. After evaporating this, it was freeze-dried after filtration.
[0012]
(Production Example 2)
300 g of a 50% aqueous ethanol solution was added to 10 g of the seeds of a dried scutellaria, and the mixture was allowed to stand for 5 days with occasional stirring. After evaporating this, it was freeze-dried after filtration.
[0013]
(Production Example 3)
300 ml of purified water is added to 10 g of the seeds of Datura stramonium (dry product) and heated for 3 hours. This was allowed to cool, filtered, and lyophilized.
[0014]
Figure 0003545057
[0015]
Figure 0003545057
A and B were each weighed and heated to 70 ° C., A was gradually added to B with stirring, and then cooled to 30 ° C. with slow stirring.
[0016]
Example 3 was prepared by changing the extract of Production Example 1 of Example 1 to the extract of Production Example 3.
[0017]
(Tyrosinase activity inhibition test)
(Test method)
0.9 ml of McClbaln buffer solution, 1.0 ml of 1.66 mM tyrosine solution, 0.1 wt / v% aqueous solution of the above-mentioned production example (lyophilized product) (ethanol was added if it was difficult to dissolve) and dissolved. Thereafter, purified water was added thereto, and the mixture was evaporated and ethanol was removed. Then, 1.0 ml of the resulting mixture was adjusted to 0.1 wt / v%) was taken in a screw vial, and heated in a 37 ° C constant temperature water bath for 5 minutes or more.
0.1 ml of a tyrosinase solution (manufactured by Sigma, derived from mushrooms, 914 units / ml) was added, the temperature was kept in a constant temperature water bath at 37 ° C., and the absorbance was measured at 475 nm after 10 minutes.
As a control, pure water was added instead of the sample solution, and the measurement was performed in the same manner.
In this test, the final concentration of the sample is 0.033%.
Figure 0003545057
Table 1 shows the results.
[0018]
[Table 1]
Figure 0003545057
[0019]
(Active oxygen suppression test)
There are various methods for measuring the effect of suppressing active oxygen, but the following method was used this time.
Figure 0003545057
2.4 ml of the mixture of the above reagents and 0.3 ml of the sample are added, and xanthine oxynase is added to the potassium phosphate buffer so that the absorbance increases by about 0.02 per minute when the experiment is carried out using water as the sample in advance. 0.1 ml of the solution (adjusted with the solution) and immediately measure the absorbance (560 nm). (Measurements are divided into two and linearity is confirmed)
Calculation formula Inhibition rate = ((AB) / A) × 100
A: Change in absorbance per minute when the sample was water B: Change in absorbance per minute of the sample Several steps were performed to find the 50% active oxygen production inhibitory concentration. A sample was prepared by dissolving the above-mentioned production example (freeze-dried product) in an aqueous solution having an appropriate concentration (if it is difficult to dissolve, adding ethanol to the solution, adding purified water to the solution, evaporating the solution, removing the ethanol, and then removing an appropriate concentration% It was prepared so that it might become.
Table 2 shows the results of the 50% active oxygen production inhibition concentration for Production Example 2.
[0020]
[Table 2]
Figure 0003545057
[0021]
(Antioxidant test)
The following test solutions were prepared in 50 ml test tubes with screw caps.
Sample 5mg
10% 2% linoleic acid ethanol solution
0.1 M, pH 7.0 phosphate buffer 10 ml
5 ml of purified water
This is left in a constant temperature bath at 50 ° C., protected from light.
The following measurements were taken before putting this in a thermostat and at intervals of several days.
0.125 ml of test solution, 12.125 ml of 75% ethanol and 0.125 ml of 30% ammonium thiocyanate were added, stirred and left for 3 minutes, and 0.12 ml of 0.02N ferrous chloride 3.5% HCl aqueous solution was added. After stirring and leaving for 3 minutes, the absorbance was measured at a wavelength of 500 nm. The cell length was 10 mm, and the control cell was one in which the test solution was replaced with water.
The results are shown in Tables 3 and 4.
[0022]
[Table 3]
Figure 0003545057
[0023]
[Table 4]
Figure 0003545057
[0024]
(Use test)
The face of each of six women was divided into left and right, one of which was used as an example and the other was used as a comparative example at least once a day. In the comparative examples, various extracts of Aspergillus vulgaris from the examples were replaced with water. (Comparative Examples 1 and 2) Twelve people were divided into two groups, and experiments were performed using the samples shown in Table 5 below.
[0025]
[Table 5]
Figure 0003545057
[0026]
The criteria are as follows, and the total of the scores is summarized in Table 6 below.
Example is much better 3
Example is considerably better 2
Example is slightly better 1
No difference 0
Comparative example is slightly better -1
Comparative example is much better -2
Comparative example is much better -3
[0027]
[Table 6]
Figure 0003545057
[0028]
【The invention's effect】
The cosmetic of the present invention is excellent in whitening effect, active oxygen suppressing effect and antioxidant effect, so that the effect of preventing rough skin is great.
Since ancient times, it has been used as an oral medicine, so it is guaranteed in terms of safety for the human body.

Claims (1)

シロバナチョウセンアサガオの種子から、水或いは親水性有機溶媒、又はこれらの混合溶媒で抽出した抽出物を含む化粧料。A cosmetic comprising an extract obtained by extracting water or a hydrophilic organic solvent, or a mixed solvent thereof, from seeds of Asparagus japonicum.
JP20728794A 1994-08-31 1994-08-31 Cosmetics Expired - Fee Related JP3545057B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20728794A JP3545057B2 (en) 1994-08-31 1994-08-31 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20728794A JP3545057B2 (en) 1994-08-31 1994-08-31 Cosmetics

Publications (2)

Publication Number Publication Date
JPH0867616A JPH0867616A (en) 1996-03-12
JP3545057B2 true JP3545057B2 (en) 2004-07-21

Family

ID=16537302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20728794A Expired - Fee Related JP3545057B2 (en) 1994-08-31 1994-08-31 Cosmetics

Country Status (1)

Country Link
JP (1) JP3545057B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919218B1 (en) * 1997-03-19 2004-05-19 Shiseido Company Limited Dermatological preparations for whitening the skin
CN1203901A (en) * 1998-05-12 1999-01-06 熊军功 Rumex hybrid rumex acetosa and its application in preparation of agricultural fertilizer
EP1145709A1 (en) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Use of natural products to prepare cosmetic compositions
KR100724168B1 (en) * 2001-01-12 2007-05-31 주식회사 엘지생활건강 Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100777589B1 (en) * 2001-12-05 2007-11-16 주식회사 엘지생활건강 Composition for skin whitening containing Physalindicanol-A
ATE479752T1 (en) 2003-03-07 2010-09-15 Alnylam Pharmaceuticals Inc THERAPEUTIC COMPOSITIONS

Also Published As

Publication number Publication date
JPH0867616A (en) 1996-03-12

Similar Documents

Publication Publication Date Title
JP3193441B2 (en) Whitening cosmetics
JP2000247829A (en) Cosmetic, unregulated drug, medicine and food
JP3558349B2 (en) Whitening cosmetics
JP3545057B2 (en) Cosmetics
JP3170040B2 (en) Whitening cosmetics
JP3235922B2 (en) Cosmetics
JP2600036B2 (en) Cosmetics
JP2690421B2 (en) Cosmetics
JPH0687731A (en) Cosmetic
JP3496967B2 (en) Antiplasmin agent
JP3235919B2 (en) Cosmetics
JP2020070258A (en) Antioxidant, anti-glycation agent, hyaluronidase inhibitor, and cosmetics
JP3113009B2 (en) Whitening cosmetics
JP3206952B2 (en) Antioxidant
JP3176983B2 (en) Whitening cosmetics
JP2001048768A (en) Cosmetic, quasi-drug, drug and food
JPH10109924A (en) Beautifying and whitening cosmetic
JP3792745B2 (en) Tyrosinase inhibitor
JPH0597653A (en) Cosmetic
JP3547155B2 (en) Active oxygen suppressant
JPH0597649A (en) Cosmetic
JP2778855B2 (en) Cosmetics
JP3461921B2 (en) Cosmetics
JPH0867617A (en) Cosmetic
JPH07291873A (en) Collagenase inhibitor

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040330

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040407

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees